MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GRUNEWALD, G. L.
Right arrow Articles by KRASS, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GRUNEWALD, G. L.
Right arrow Articles by KRASS, P.

Molecular Pharmacology, Vol 20, 377-381, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Conformational Preferences of Amphetamine Analogues for Inhibition of Phenylethanolamine N-Methyltransferase

Conformationally Defined Adrenergic Agents. 5

GARY L. GRUNEWALD 1, RONALD T. BORCHARDT 1, MICHAEL F. RAFFERTY 1, and POLINA KRASS 1

1 Departments of Medicinal Chemistry and Biochemistry, University of Kansas, Lawrence, Kansas 66045

A series of conformationally defined amphetamine analogues was examined for their ability to inhibit competitively the enzyme phenylethanolamine N-methyltransferase (PNMT). Among these were compounds based on the benzobicyclo-[2.2.1]heptene and the benzobicyclo-[2.2.2]octene structures which, depending upon the point of the attachment of the amino group, closely approximate a trans antiperiplanar or a gauche conformation of amphetamine. Some more flexible conformationally restricted amphetamine analogues which had been previously evaluated as inhibitors of PNMT were included in the study for comparison. In all cases, those compounds which mimicked the gauche conformation of amphetamine failed to inhibit competitively PNMT, whereas compounds which approximated a fully extended (trans antiperiplanar) conformation showed significant inhibition. Therefore, the indication from the data is that phenylethylamines must be able to achieve a fully extended conformation of the side chain in order to bind to the PNMT active site.

Note:
ACKNOWLEDGMENTS We gratefully acknowledge the efforts of Brian Andrews, Daniel Flynn, Stephen Jacober, Julie Matthews, Dr. Thomas Reitz, Theresa Rothauser, Dr. James Ruth, and Dr. Eric Walters in the preparation of some of the compounds used in the study.

Submitted on February 2, 1981
Accepted on April 21, 1981







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics